주식회사다인약품
주식회사다인약품's KOBDi Score is 27.80 as of Sep 2026, up 0.16 points since Apr 2025; it rose in 1 of the 12 monthly updates and never fell. As of Sep 2026 it is ahead of about 83% of companies in its industry, against 83% in Aug 2026 and 80% in Apr 2025. Its strongest position was 84% (Apr 2026) and its weakest 80% (Apr 2025).
A year earlier, in Aug 2025, its score was 27.64 and it was ahead of about 82% of companies in its industry.
| Sep 2026 | 27.80 | ahead of 83% |
| Aug 2026 | 27.80 | ahead of 83% |
| Jul 2026 | 27.80 | ahead of 83% |
| Jun 2026 | 27.80 | ahead of 83% |
| May 2026 | 27.80 | ahead of 83% |
| Apr 2026 | 27.80 | ahead of 84% |
| Mar 2026 | 27.80 | ahead of 83% |
| Feb 2026 | 27.80 | ahead of 83% |
| Dec 2025 | 27.80 | ahead of 83% |
| Aug 2025 | 27.64 | ahead of 82% |
| Jul 2025 | 27.64 | ahead of 82% |
| May 2025 | 27.64 | ahead of 81% |
| Apr 2025 | 27.64 | ahead of 80% |
Where is 주식회사다인약품 located?
주식회사다인약품 is registered at 충청남도 공주시 왕촌안길, South Korea (postal code 34414).
What industry is 주식회사다인약품 in?
주식회사다인약품 belongs to Wholesale & Retail Trade › Wholesale – Household Goods & Appliances › Pharmaceutical wholesaler.
How many employees does 주식회사다인약품 have?
주식회사다인약품 has 1–4 employees.
What is 주식회사다인약품's KOBDi Score?
27.80 as of September 2026, ahead of about 83% of companies in its industry.
Who are 주식회사다인약품's competitors?
Similar companies include sam sung pharm, daeil pharm and sbmedteck.
